Our LDH release and calcium staining assays showed that IL-22 treatment prominently inhibited NK cell-mediated lysis of HCC cells, but STAT3 knockdown significantly mitigated this effect, indicating IL-22-induced STAT3 activation surely endowed HCC cell resistance to NK cell-mediated killing. This evidence concerns the gene IL22 and hepatocellular carcinoma.